1-1 of 1 results for subject:Pfizer
Librarians' tools
- Search time
- 0.177 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Pfizer
- We searched for
- subject_t:Pfizer OR subject_ses:61578
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the efficacy of the Pfizer-BioNTech covid-19 vaccine after twelve weeks.
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the efficacy of the Pfizer-BioNTech covid-19 vaccine after twelve weeks.
The Joint Committee for Vaccinations and Immunisations (JCVI) advises a two-dose vaccine schedule for the Pfizer-BioNTech and AstraZeneca vaccines. The JCVI advises a maximum interval between the first and second doses of 12 weeks. The JCVI has considered published data on the effectiveness of the Pfizer-BionTech vaccine, where follow up extended to around thirteen weeks after the second dose.